These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24752659)

  • 1. Oxidative stress and the antipsychotic-induced vacuous chewing movement model of tardive dyskinesia: evidence for antioxidant-based prevention strategies.
    Lister J; Nobrega JN; Fletcher PJ; Remington G
    Psychopharmacology (Berl); 2014 Jun; 231(11):2237-49. PubMed ID: 24752659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
    Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Lv MH; Zhou DF; Soares JC; Kosten TR; Yang FD; Zhang XY
    Behav Brain Res; 2016 Jan; 297():124-30. PubMed ID: 26455874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats.
    Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Puntel RL; Paixão MW; Braga AL; Calixto JB; Rocha JB; Ferreira J
    Psychopharmacology (Berl); 2007 Oct; 194(3):423-32. PubMed ID: 17641876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
    Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
    McCormick SE; Stoessl AJ
    Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
    Naidu PS; Kulkarni SK
    Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
    Naidu PS; Singh A; Kulkarni SK
    Br J Pharmacol; 2002 May; 136(2):193-200. PubMed ID: 12010767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgo biloba leaf extract and alpha-tocopherol attenuate haloperidol-induced orofacial dyskinesia in rats: Possible implication of antiapoptotic mechanisms by preventing Bcl-2 decrease and Bax elevation.
    An HM; Tan YL; Shi J; Wang Z; Lv MH; Soares JC; Zhou D; Yang F; Zhang XY
    Phytomedicine; 2016 Dec; 23(13):1653-1660. PubMed ID: 27823630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
    Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
    Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
    Tamminga CA; Dale JM; Goodman L; Kaneda H; Kaneda N
    Psychopharmacology (Berl); 1990; 102(4):474-8. PubMed ID: 1982902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
    Turrone P; Remington G; Kapur S; Nobrega JN
    Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the effects of cannabidiol on vacuous chewing movements, locomotion, oxidative stress and blood glucose in rats treated with oral haloperidol.
    Kajero JA; Seedat S; Ohaeri J; Akindele A; Aina O
    World J Biol Psychiatry; 2020 Oct; 21(8):612-626. PubMed ID: 32264772
    [No Abstract]   [Full Text] [Related]  

  • 15. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
    Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
    Turrone P; Remington G; Kapur S; Nobrega JN
    Neuropsychopharmacology; 2003 Aug; 28(8):1433-9. PubMed ID: 12838271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B vitamins attenuate haloperidol-induced orofacial dyskinesia in rats: possible involvement of antioxidant mechanisms.
    Macêdo DS; Oliveira GV; Gomes PX; Araújo FY; Souza CM; Vasconcelos SM; Viana GS; Sousa FC; Carvalho AF
    Behav Pharmacol; 2011 Oct; 22(7):674-80. PubMed ID: 21918383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats.
    Pereira RP; Fachinetto R; de Souza Prestes A; Wagner C; Sudati JH; Boligon AA; Athayde ML; Morsch VM; Rocha JB
    J Neural Transm (Vienna); 2011 Nov; 118(11):1547-57. PubMed ID: 21476069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats.
    Thaakur S; Himabindhu G
    J Neural Transm (Vienna); 2009 Jul; 116(7):807-14. PubMed ID: 19444377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba and vitamin E ameliorate haloperidol-induced vacuous chewingmovement and brain-derived neurotrophic factor expression in a rat tardive dyskinesia model.
    Shi J; Tan YL; Wang ZR; An HM; Li J; Wang YC; Lv MH; Yan SX; Wu JQ; Soares JC; Yang FD; Zhang XY
    Pharmacol Biochem Behav; 2016 Sep; 148():53-8. PubMed ID: 27264436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.